Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvancedadvt Regulatory News (ADVT)

Share Price Information for Advancedadvt (ADVT)

Share Price is delayed by 15 minutes
Get Live Data
155.00    0.00 (0.00%)
Bid:
150.00
Ask:
160.00
Spread: 10.00 (6.667%)
Market Cap: £205.12m
ADVT Live PriceLast checked at - London Stock Exchange

Intraday Advancedadvt Share Chart

Director/PDMR Shareholding

24 May 2024 11:15

RNS Number : 8563P
AdvancedAdvT Limited
24 May 2024
 

24 May 2024

 

AdvancedAdvT Limited

 

PDMR Dealings

 

AdvancedAdvT Limited (AIM: ADVT, "AdvT", "the Group"), the international software solutions provider for the business solutions, healthcare compliance, and human capital management sectors has been notified that on 23 May 2024 Barbara Firth, Non-Executive Director and Senior Independent Director, purchased 70,000 ordinary shares of no par value ("Ordinary Shares") at a price of £1.41 per Ordinary Share.

 

Following the completion of the transaction, Barbara Firth's total beneficial interest in the Company stands at 70,000 Ordinary Shares, representing 0.05% of the total issued share capital.

 

Details of the transaction can be found in the Notification of Dealing Form below.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Barbara Firth

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director and Senior Independent Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

AdvancedAdvT Limited

b)

 

LEI

 

 

254900WYO35S1T334A28

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of no par value fully paid (DI)

Identification code

VGG0103J1075

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£1.41

70,000

d)

 

Aggregated information

- Aggregated volume

n/a

- Price

n/a

e)

 

Date of the transaction

 

 

23 May 2024

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

 

Enquiries:

 

AdvancedAdvT Limited

Vin Murria, Chairperson

Gavin Hugill, Chief Financial Officer

c/o Meare Consulting

Singer Capital Markets (Nominated Adviser and Broker)

Tel: 020 7496 3000

Philip Davies / Asha Chotai / Sam Butcher

KK Advisory (Investor Relations)

Tel: 020 7039 1901

Kam Bansil 

 

Meare Consulting 

Adrian Duffield

Tel: 07990 858548

 

Note to Editors

 

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.

The Group's operations are IBSS (financial management software), CHKS (AI based healthcare intelligence compliance and accreditation software), Retain (global resource planning and talent management software) and WFM (workforce management software provider).

AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in these sectors where long term digitisation trends are set to transform the workplace for professionals. 

AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGGDURGDDGSS
Date   Source Headline
26th Sep 202211:44 amRNSForm 8.5 (EPT/RI)
26th Sep 202210:36 amGNWRule 8.3 - AdvancedAdvT Limited
26th Sep 20227:00 amRNSUpdate on Acceptance Levels
23rd Sep 20227:00 amRNSUpdate on Acceptance Levels
23rd Sep 20227:00 amRNSUpdate on Acceptance Levels
22nd Sep 20227:00 amRNSUpdate on Acceptance Levels
21st Sep 20229:03 amRNSForm 8.5 (EPT/RI)
20th Sep 202210:37 amRNSForm 8.3 - ADVT
20th Sep 202210:20 amRNSForm 8.5 (EPT/RI)
16th Sep 20229:02 amRNSForm 8.5 (EPT/RI)
15th Sep 20221:11 pmRNSForm 8.3 - AdvancedAdvT Limited
15th Sep 202212:04 pmRNSForm 8.5 (EPT/RI)
15th Sep 202211:00 amRNSNet Asset Value(s)
15th Sep 20227:00 amRNSUpdate on Acceptance Levels
14th Sep 202210:40 amRNSForm 8.5 (EPT/RI)
13th Sep 20229:06 amRNSForm 8.5 (EPT/RI)
13th Sep 20227:00 amRNSContinued Rejection of ADV Offer
12th Sep 20229:21 amRNSForm 8.5 (EPT/RI)
9th Sep 202210:19 amRNSForm 8.5 (EPT/RI)
8th Sep 202210:28 amRNSResponse to ADV’s Acceleration Statement
8th Sep 20227:00 amRNSAcceleration Statement
2nd Sep 202212:00 pmRNSForm 8.5 (EPT/RI)
1st Sep 202210:11 amRNSForm 8.5 (EPT/RI)
31st Aug 202210:26 amRNSForm 8.5 (EPT/RI)
22nd Aug 20221:47 pmRNSForm 8.3 - M&C SAATCHI
22nd Aug 202211:07 amRNSForm 8.5 (EPT/RI)
19th Aug 202211:00 amRNSAdjournment of M&C Saatchi Meetings
16th Aug 20221:00 pmRNSForm 8.3 - M&C SAATCHI
16th Aug 20227:00 amRNSUpdate on Final Offer for M&C Saatchi
15th Aug 20224:45 pmRNSUpdate for Shareholders on Regulatory Filings
15th Aug 20223:06 pmRNSForm 8.3 - M&C SAATCHI
15th Aug 202211:59 amRNSUpdate on Final Offer for M&C Saatchi
12th Aug 20223:32 pmRNSForm 8.3 - M&C SAATCHI
10th Aug 20223:03 pmRNSForm 8.3 - M&C SAATCHI
10th Aug 202211:45 amRNSForm 8.5 (EPT/RI)
9th Aug 20222:20 pmRNSForm 8.3 - M&C SAATCHI
9th Aug 20229:00 amRNSForm 8.5 (EPT/RI)
4th Aug 20229:16 amRNSForm 8.5 (EPT/RI)
3rd Aug 202211:28 amRNSForm 8.5 (EPT/RI) - Advancedadvt Limited
2nd Aug 20222:34 pmRNSForm 8.3 - M&C SAATCHI
2nd Aug 20229:55 amRNSForm 8.5 (EPT/RI)
1st Aug 20229:45 amRNSForm 8.5 (EPT/RI)
29th Jul 20222:43 pmRNSForm 8.3 - M&C SAATCHI
27th Jul 20222:30 pmRNSForm 8.3 - Next Fifteen Communications Group plc
27th Jul 202210:39 amRNSForm 8.5 (EPT/RI)
26th Jul 202210:45 amGNWForm 8.3 - [ADVANCEDADVT LIMITED 25 07 2022] - HHL
26th Jul 202210:06 amRNSForm 8.5 (EPT/RI)
25th Jul 202210:31 amRNSStatement re M&C Saatchi offer timetable
22nd Jul 20222:19 pmRNSForm 8.3 - M&C SAATCHI
21st Jul 202212:44 pmRNSForm 8.3 - AdvancedAdvT Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.